ArticleGenes & diseases2025

A novel oridonin analogue, CYD0682, suppresses breast cancer growth, angiogenesis, and metastasis by inhibiting the ANGPTL4/MAPK signaling axis.

Xiaobin Mai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.